The Federal Trade Commission has approved Allergan's ( AGN) proposed acquisition of Inamed ( IMDC), a health care company. This approval was the final antitrust approval required for the acquisition.

Allergan confirmed the expiration time for the offer is Friday. Allergan is offering $84 in cash, or 0.8498 share of Allergan for each outstanding share of Inamed. As per the offer, 45% of Inamed shares tendered will be exchanged for cash and 55% will get Allergan stock.

"We are pleased to have received U.S. antitrust approval from the FTC, and we look forward to rapidly completing the Inamed acquisition so we can initiate our integration plan," Allergan said. "We expect to finalize the acquisition as promptly as possible after the exchange offer is completed."

This story was created through a joint venture between TheStreet.com and IRIS.

More from Stocks

Finding Stocks Right for You: Cramer's 'Mad Money' Recap (Friday 8/25/18)

Finding Stocks Right for You: Cramer's 'Mad Money' Recap (Friday 8/25/18)

Flashback Friday: Amazon, Chip Stocks, Memorial Day

Flashback Friday: Amazon, Chip Stocks, Memorial Day

Week Ahead: Wall Street Looks to Jobs Report as North Korea Meeting Less Certain

Week Ahead: Wall Street Looks to Jobs Report as North Korea Meeting Less Certain

Dow and S&P 500 Decline, Energy Shares Fall as U.S. Crude Oil Slides 4%

Dow and S&P 500 Decline, Energy Shares Fall as U.S. Crude Oil Slides 4%

Replay: Jim Cramer on the Markets, 10-Year Yield, Oil Prices and Foot Locker

Replay: Jim Cramer on the Markets, 10-Year Yield, Oil Prices and Foot Locker